Precision Health: The Future of Personalized Medicine
How AI, Big Data, and Genomics Are Revolutionizing Healthcare and Patient Care
On October 9-10, 2024, at One World Trade Center in New York City, global leaders and innovators will gather for the 2024 Precision Health Summit, an event poised to redefine the future of healthcare. In an era where artificial intelligence (AI), big data, and genomics are transforming industries, the healthcare sector stands at the threshold of a revolutionary shift—moving from a one-size-fits-all approach to truly personalized medicine. This summit, with its dual focus on business strategies and scientific advances, will offer critical insights into how personalized healthcare solutions can deliver better patient outcomes while also creating new market opportunities.
The Next Frontier in Healthcare: Data-Driven Personalization
Ali Mostashari, founder and CEO of LifeNome, will open the summit by exploring the intersection of AI and healthcare, particularly how data-driven personalization is unlocking new possibilities in human longevity and wellness. His firm’s pioneering work in genomics-based personalization is emblematic of the broader trend of integrating AI into healthcare to offer customized treatment and wellness plans based on individual genetic profiles.
Complementing Mostashari’s technological outlook, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. Food and Drug Administration (FDA), will provide a regulatory perspective that underscores the challenges and necessities of developing safe and effective gene therapies. Marks will illuminate how the FDA is adapting to the rapid pace of innovation while ensuring that safety and efficacy remain paramount in this new frontier of healthcare.
Incorporating innovation into large corporate structures is no small feat, yet LG Electronics is doing just that. Joshua Di Frances, head of incubation and venture building at LG, will discuss how global corporations are building innovation hubs to explore and commercialize precision health technologies. His session will provide attendees with practical insights into how established enterprises can successfully engage with cutting-edge fields like personalized medicine.
Public Engagement and the Human Element
While technology drives much of the transformation in precision health, engaging the public and building trust remains critical. Willie Reaves, head of public engagement at Cellino, will tackle this crucial aspect. Reaves will argue that without patient buy-in and an informed public, even the most advanced healthcare technologies will struggle to gain widespread adoption. His presentation will focus on strategies for effectively communicating the benefits and addressing the concerns around personalized medicine.
On the clinical front, Raya Khanin, chief scientist at LifeNome, will highlight how AI and biological data are being harnessed to address the specific healthcare needs of women. Her session will delve into how personalized approaches, particularly in preventive care, are improving outcomes in women’s health. Similarly, Poroshat Shekarloo, director of global health at Maimonides Medical Center, will expand the conversation by focusing on maternal health, illustrating how precision medicine is bringing more tailored solutions to this critical area of healthcare.
Global Perspectives and Investment Strategies
Personalized medicine is a global movement, and it requires international collaboration. Andy Moose, head of health and wellness at the World Economic Forum, will offer a broad, global perspective on how different countries are adopting and advancing precision health. Moose’s session will examine the role of cross-border partnerships in scaling personalized healthcare solutions, particularly in developing regions where disparities in healthcare access remain stark.
Investors, too, are paying close attention. Martin Alexander Gershon, principal at Endeavor Venture Fund and Venture Studio, will lead a discussion on the growing financial opportunities in precision health. Gershon’s analysis will cover the investment landscape, exploring the risks and rewards for venture capitalists and private equity investors. As more startups enter the space, Gershon will help investors understand where they should place their bets.
On the data side, Asieh Golozar, VP and global head of data science at Odysseus Data Services, will delve into the vital role that standardized, real-world evidence plays in precision health. Golozar will demonstrate how integrating structured data into healthcare systems can lead to more accurate diagnoses and improved patient outcomes. William Weeks, director of AI for health at Microsoft, will further this discussion by showing how AI can analyze vast healthcare datasets to identify trends and inform treatment decisions in real time.
Commercialization Challenges: Bringing Precision Health to Market
Commercializing precision health technologies presents unique challenges, especially in navigating complex regulatory environments and scaling innovations for global markets. Gabriele Allegri, VP of global commercial precision medicine at Johnson & Johnson Innovative Medicine, will outline strategies for overcoming these barriers. Allegri’s session will be particularly relevant to companies looking to scale breakthrough innovations without losing sight of regulatory and market dynamics.
Aquil Harjivan, R&D Head of Front-End Innovation at Bayer, will discuss how early-stage research and innovation are shaping the future of precision health. He will explore the integration of cutting-edge technologies into R&D pipelines, highlighting how these innovations can accelerate the development of personalized healthcare solutions.
Recommended by LinkedIn
In diagnostics, Lee-Anne Zinetti, executive director for healthcare systems and diagnostics at Novartis, will discuss how advancements in diagnostic technologies are enabling earlier detection of diseases and more personalized treatment plans. Zinetti will argue that diagnostics are not just a supporting tool but are central to the evolution of precision health, providing actionable data that drives personalized treatment options.
The Role of AI and Technology in Advancing Precision Medicine
The role of technology in precision health is expanding rapidly. Arda Ural, Americas life sciences leader at EY, will discuss how AI and big data are being harnessed by life sciences organizations to innovate more effectively and deliver personalized healthcare solutions. Ural’s talk will highlight how AI is not only optimizing clinical trials but also helping healthcare providers personalize treatments at an unprecedented scale.
Fern Lazar, Managing Partner and Global Health Practice Leader at FINN Partners, will address the critical role of strategic communications in advancing precision health. She will discuss how effective public relations and stakeholder engagement can build trust, drive awareness, and facilitate the adoption of personalized healthcare solutions, ensuring that innovations reach patients and providers in meaningful ways.
As personalized medicine gains traction globally, regional markets are emerging as significant players. Alfredo Carvajal, an expert in Latin American healthcare markets, will explore how precision health technologies are being adapted and applied in Latin America. Carvajal will offer insights into the specific challenges and opportunities in this growing market, including regulatory hurdles and the potential for local innovation.
Mario Storga, a machine learning expert, will provide an in-depth look at how AI is being used to develop more precise and individualized treatment plans. His session will explore the state of the art in machine learning for healthcare and the future potential of AI to not only diagnose but also predict and prevent medical conditions.
Leon Eisen, an investor focused on wearable technologies, will close the summit by discussing the role of real-time data in precision health. Wearable devices, Eisen will argue, are revolutionizing patient care by providing continuous data that can be used to tailor treatments and monitor patients in real time. His insights will be invaluable for those looking to invest in or develop wearable health technologies.
A Vision for the Future of Healthcare
The 2024 Precision Health Summit offers a comprehensive view into the future of healthcare, where advanced technologies like AI, big data, and genomics will transform how we diagnose, treat, and prevent diseases. As healthcare shifts from a generalized approach to a more individualized one, this summit will explore how these innovations are making personalized care a reality—improving patient outcomes, reducing costs, and reshaping the industry at its core.
From AI-driven diagnostic tools to wearable technologies providing real-time data, precision health is redefining the patient experience, allowing for more proactive, customized treatment options. The conversations at the summit will focus on the practical, actionable steps required to scale these innovations globally and make personalized medicine the new standard in healthcare.
Attendees will gain deep insights into the intersection of science, technology, and business, leaving with a clearer understanding of how to lead in this rapidly evolving landscape. As the summit brings together key players from various industries, it will highlight the critical role collaboration and innovation play in driving this transformation forward.
The 2024 Precision Health Summit marks a pivotal moment for those invested in the future of healthcare, as the possibilities of precision medicine move from theory to practice, offering a clear path toward a healthier, more personalized tomorrow.
>>> FOR MORE INFORMATION ON THE SPEAKERS, THE PROGRAM AND TO REGISTER, PLEASE VISIT THE SUMMIT SITE:
Ali Mostashari, Ph.D Peter Marks Joshua Di Frances Willie T. Reaves Jr. Raya Khanin Poroshat Shekarloo MD Andy Moose Dr. D. Martin Alexander Gershon, MD, JD, MPH Asieh Golozar Gabriele Allegri Aquil Harjivan Lee-Anne Zinetti Matthias Wagner Parastoo Khoshakhlagh, Ph.D. Christina Kotsi Fern Lazar William Brinson Weeks, MD, PhD, MBA Arda Ural, MSc, MBA, PhD Alfredo Carvajal Mario Storga Leon Eisen, PhD Gil Bashe Glenn Tyranski Henning Stein, PhD, GCB.D